Platelet activity and aspirin efficacy after off-pump compared with on-pump coronary artery bypass surgery: Results from the prospective randomized trial PRAGUE 11-Coronary Artery Bypass and REactivity of Thrombocytes (CABARET)

Journal of Thoracic and Cardiovascular Surgery

Volumn 136, Issue 4, 2008, Pages 1054-1060

  Bednar, Frantisek ^a   Osmancik, Pavel ^a   Vanek, Tomas ^a   Mocikova, Heidi ^a   Jares, Martin ^a   Straka, Zbynek ^a   Widimsky, Petr ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ARACHIDONIC ACID; CLOPIDOGREL; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; PADGEM PROTEIN; PROTAMINE;

ADULT; AGED; ARTICLE; BLOOD CLOTTING TIME; BLOOD SAMPLING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG INHIBITION; FEMALE; FLOW CYTOMETRY; HEMOSTASIS; HUMAN; MAJOR CLINICAL STUDY; MALE; OFF PUMP CORONARY SURGERY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; THROMBOCYTE FUNCTION; THROMBOSIS;

AGED; ASPIRIN; CONFIDENCE INTERVALS; CORONARY ARTERY BYPASS; CORONARY ARTERY BYPASS, OFF-PUMP; CORONARY STENOSIS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; MALE; MIDDLE AGED; P-SELECTIN; PLATELET ACTIVATION; PLATELET AGGREGATION; PLATELET COUNT; POSTOPERATIVE CARE; PREOPERATIVE CARE; PROBABILITY; PROGNOSIS; PROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL ANALYSIS; THROMBOPLASTIN; TREATMENT OUTCOME;

EID: 54149116512     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2008.03.052     Document Type: Article

References (29)

1. Khuri S.F., Wolfe J.A., Josa M., Axford T.C., Szymanski I., Assousa S., et al. Hematologic changes during and after cardiopulmonary bypass and their relationship to the bleeding time and nonsurgical blood loss. J Thorac Cardiovasc Surg 104 (1992) 94-107
2. Paparella D., Brister S.J., and Buchanan M.R. Coagulation disorders of cardiopulmonary bypass: a review. Intensive Care Med 30 (2004) 1873-1881
3. Sellke F.W., DiMaio J.M., Caplan L.R., Ferguson T.B., Gardner T.J., Hiratzka L.F., et al. Comparing on-pump and off-pump coronary artery bypass grafting: numerous studies but few conclusions: a scientific statement from the American Heart Association council on cardiovascular surgery and anesthesia in collaboration with the interdisciplinary working group on quality of care and outcomes research. Circulation 111 (2005) 2858-2864
4. Lo B., Fijnheer R., Castigliego D., Borst C., Kalkman C.J., and Nierich A.P. Activation of hemostasis after coronary artery bypass grafting with or without cardiopulmonary bypass. Anesth Analg 99 (2004) 634-640
5. Quigley R.L., Fried D.W., Salenger R., Pym J., and Highbloom R.Y. Thrombelastographic changes in OPCAB surgical patients. Perfusion 17 (2002) 363-367
6. Mariani M.A., Gu Y.J., Boonstra P.W., Grandjean J.G., van Oeveren W., and Ebels T. Procoagulant activity after off-pump coronary operation: is the current anticoagulation adequate?. Ann Thorac Surg 67 (1999) 1370-1375
7. Kurlansky P.A. Is there a hypercoagulable state after off-pump coronary artery bypass surgery? What do we know and what can we do?. J Thorac Cardiovasc Surg 126 (2003) 7-10
8. Ballotta A., Saleh H.Z., El Baghdady H.W., Gomaa M., Belloli F., Kandil H., et al. Comparison of early platelet activation in patients undergoing on-pump versus off-pump coronary artery bypass surgery. J Thorac Cardiovasc Surg 134 (2007) 132-138
9. Moller C.H., and Steinbruchel D.A. Platelet function after coronary artery bypass grafting: is there a procoagulant activity after off-pump compared with on-pump surgery?. Scand Cardiovasc J 37 (2003) 149-153
10. Bidstrup B.P., Scarrott H., and Luque M. Platelet function after off pump coronary surgery. Heart Surg Forum 6 (2003) 286-287
11. Gerrah R., Snir E., Brill A., and Varon D. Platelet function changes as monitored by cone and plate(let) analyzer during beating heart surgery. Heart Surg Forum 7 (2004) E191-E195
12. Collaborative overview of randomised trials of antiplatelet therapy-II: maintenance of vascular graft or arterial patency by antiplatelet therapy. Antiplatelet Trialists' Collaboration. BMJ 308 (1994) 159-168
13. Vanek T., Brucek P., and Straka Z. Fast track as a routine for open-heart surgery. Eur J Cardiothorac Surg 21 (2002) 369-370
14. Straka Z., Widimsky P., Jirasek K., Stros P., Votava J., Vanek T., et al. Off-pump versus on-pump coronary surgery: final results from a prospective randomized study PRAGUE-4. Ann Thorac Surg 77 (2004) 789-793
15. Michelson A.D. Platelet function testing in cardiovascular diseases. Circulation 110 (2004) e489-e493
16. Osmancik P.P., Bednar F., Mocikova H., Stros P., Jirasek K., Straka Z., et al. The comparison of platelet activity between patients with patent vs. occluded coronary artery bypass grafts. Thromb Res 120 (2007) 523-529
17. Burke J., Kraft W.K., Greenberg H.E., Gleave M., Pitari G.M., VanBuren S., et al. Relationship of arachidonic acid concentration to cyclooxygenase-dependent human platelet aggregation. J Clin Pharmacol 43 (2003) 983-989
18. Poston R., Gu J., Brown J., Gammie J., White C., Manchio J., et al. Hypercoagulability affecting early vein graft patency does not exist after off-pump coronary artery bypass. J Cardiothorac Vasc Anesth 19 (2005) 11-18
19. Poston R., Gu J., Manchio J., Lee A., Brown J., Gammie J., et al. Platelet function tests predict bleeding and thrombotic events after off-pump coronary bypass grafting. Eur J Cardiothorac Surg 27 (2005) 584-591
20. Parolari A., Mussoni L., Frigerio M., Naliato M., Alamanni F., Polvani G.L., et al. The role of tissue factor and P-selectin in the procoagulant response that occurs in the first month after on-pump and off-pump coronary artery bypass grafting. J Thorac Cardiovasc Surg 130 (2005) 1561-1566
21. Czerny M., Baumer H., Kilo J., Zuckermann A., Grubhofer G., Chevtchik O., et al. Complete revascularization in coronary artery bypass grafting with and without cardiopulmonary bypass. Ann Thorac Surg 71 (2001) 165-169
22. Blann A.D., Nadar S.K., and Lip G.Y. The adhesion molecule P-selectin and cardiovascular disease. Eur Heart J 24 (2003) 2166-2179
23. Kabbani S.S., Watkins M.W., Ashikaga T., Terrien E.F., Holoch P.A., Sobel B.E., et al. Platelet reactivity characterized prospectively: a determinant of outcome 90 days after percutaneous coronary intervention. Circulation 104 (2001) 181-186
24. Tschoepe D., Schultheiss H.P., Kolarov P., Schwippert B., Dannehl K., Nieuwenhuis H.K., et al. Platelet membrane activation markers are predictive for increased risk of acute ischemic events after PTCA. Circulation 88 (1993) 37-42
25. Li N., Hu H., and Hjemdahl P. Aspirin treatment does not attenuate platelet or leukocyte activation as monitored by whole blood flow cytometry. Thromb Res 111 (2003) 165-170
26. Lordkipanidze M., Pharand C., Schampaert E., Turgeon J., Palisaitis D.A., and Diodati J.G. A comparison of six major platelet function tests to determine the prevalence of aspirin resistance in patients with stable coronary artery disease. Eur Heart J 28 (2007) 1702-1708
27. Zimmermann N., Wenk A., Kim U., Kienzle P., Weber A.A., Gams E., et al. Functional and biochemical evaluation of platelet aspirin resistance after coronary artery bypass surgery. Circulation 108 (2003) 542-547
28. Motwani J.G., and Topol E.J. Aortocoronary saphenous vein graft disease: pathogenesis, predisposition, and prevention. Circulation 97 (1998) 916-931
29. Klinkhardt U., Bauersachs R., Adams J., Graff J., Lindhoff-Last E., and Harder S. Clopidogrel but not aspirin reduces P-selectin expression and formation of platelet-leukocyte aggregates in patients with atherosclerotic vascular disease. Clin Pharmacol Ther 73 (2003) 232-241